Methadone Clinics in cities of Wisconsin
Medication Treatment for Opioid Use Disorder Across Wisconsin
Wisconsin pairs methadone clinics and office-based prescribers in its metro areas of Milwaukee, Madison, Green Bay, and the Fox Valley, with a wide rural north and west where the nearest opioid treatment program may sit a county or more away and telehealth fills the gap. The state regulates both settings under one rule, so the same three medications for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, are available statewide even where the delivery looks different from one community to the next.
This page explains how treatment works in Wisconsin and how to use the listings here to reach a provider or the helpline. The directory is organized by city, so once you know your area, you can find local options and call directly.
The Three Medications and the Two Places You Get Them
Three medications are approved to treat opioid use disorder, and can be obtained through two kinds of settings. Knowing the difference tells you what the listings on this site actually represent.
Methadone is a daily medication that steadies you and blocks withdrawal and cravings. For opioid use disorder, it is dispensed only through a federally certified opioid treatment program (OTP), the setting many people still call a methadone clinic, not at a regular pharmacy.
Buprenorphine, including the Suboxone (buprenorphine-naloxone) film and tablet and the monthly Sublocade injection, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP.
Naltrexone, including the monthly Vivitrol injection, is not an opioid and any licensed prescriber can order it. It is important to keep in mind that you have to be off opioids for a set time before beginning this treatment to avoid sudden withdrawal.
None of these is a “trade” of one drug for another. Each is an evidence-based medication successfully used to help those with OUD. These pages can help to clarify any misinformation surrounding this form of treatment. You can read how methadone and Suboxone compare, more on how methadone treatment works and what to expect at an opioid treatment program.
Wisconsin oversees clinic-based and office-based care together, so both routes follow the same state standards.
State Rules, Coverage and Funding in Wisconsin
Wisconsin regulates opioid treatment under Chapter DHS 75 of its administrative code, which sets standards for both opioid treatment programs and office-based opioid treatment (OBOT) and places both under the state’s State Opioid Treatment Authority (SOTA), the DHS subunit designated to oversee MOUD. This code also spells out guest dosing, so if you are enrolled in a program elsewhere and are temporarily in Wisconsin, a local OTP can dose you while you travel because staying at a steady, effective dose matters as much as starting.
On payment, Wisconsin’s Medicaid program, BadgerCare Plus, administered through ForwardHealth, covers all three medications for opioid use disorder: methadone, buprenorphine and naltrexone (Wisconsin Department of Health Services).
Preferred buprenorphine-naloxone products do not require prior authorization, while some non-preferred or buprenorphine-only products still do. Private insurance, Medicare Part B, and self-pay with sliding-scale fees at many programs are additional ways to cover the cost. Coverage details can change, so confirm current benefits with the provider.
Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for stable patients, decided by the program), allowed treatment to start by telehealth, and removed older admission barriers. Since 2023, any clinician with a standard DEA registration can prescribe buprenorphine, which has widened where you can get it.
As of June 2026, buprenorphine can also be started by telehealth, including by phone in many cases, without a prior in-person visit; those rules run through 2026 and are still being finalized, so confirm what is current.
If privacy at work is a concern, here is what employers can and cannot see.
Wisconsin’s Overdose Picture and Why it is Changing
Wisconsin recorded one of the largest single-year improvements in the country. Opioid overdose deaths fell from 1,422 in 2023 to 817 in 2024, a 42.5 percent drop the Wisconsin Department of Health Services has called historic. State officials credit sustained investment with this positive trajectory. However, fentanyl still drives most opioid deaths in the state, and the gains are not even across every county.
Wisconsin is receiving about $794 million in opioid settlement funds through 2038, and DHS committed roughly $31 million over two years to naloxone distribution, treatment access, prevention and recovery support.
The point of numbers like this is not alarm. It is that treatment and harm reduction work, they are funded here and a next step is available near you. You can start with how opioid use disorder is treated.
How to Find and Start Treatment in Wisconsin
Starting usually begins with an intake assessment, by phone, telehealth, or in person. During an assessment, a clinician reviews your history and helps you choose a medication and the most appropriate setting to meet your needs. Many programs offer same-week or same-day starts, so be sure to ask about that directly when you call.
If you have been using fentanyl, the timing of a first buprenorphine dose matters, because starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans that first dose with you. For some people, an OTP with daily dosing is the right fit; for others, office-based care or telehealth works better. To understand the broader options, see how Wisconsin approaches outpatient opioid use disorder treatment and, where a higher level of care is needed first, inpatient and residential options.
Use the city listings on this site to find providers in your area, then call a program or the helpline to get started.
Pregnancy, Tribal Communities and Treatment in the Justice System
Some situations carry added stakes, and Wisconsin’s settlement plan targets several of them by name.
For pregnant patients, continuing methadone or buprenorphine is the recommended standard of care, as stopping suddenly carries real risk. Therefore, treatment, not abstinence alone, is what clinical guidance supports. In addition, care teams are available to plan for the newborn, who may need monitoring for neonatal opioid withdrawal syndrome (NOWS). DHS has also directed funds to families in the Birth to 3 Program who need prevention and recovery services.
For Tribal nations, the 2026 plan dedicated $9 million, including room-and-board support for residential treatment. This funding will help to address the documented access gaps in rural and Tribal communities.
For people in or leaving jail, the state funded law-enforcement grants to expand MOUD and treatment inside county jails. Care is confidential, and seeking treatment is the protective step.
Families can start with guidance for loved ones and, for expecting patients, methadone and pregnancy.
Naloxone and Overdose Safety in Wisconsin
Naloxone reverses an opioid overdose, and Wisconsin makes it easy to get. Under a statewide standing order signed by the DHS chief medical officer, pharmacists at hundreds of enrolled pharmacies can dispense it without a personal prescription. To help increase access, over-the-counter Narcan is sold at pharmacies and stores. DHS also publishes a map of locations that give naloxone away for free.
Wisconsin’s overdose Good Samaritan law gives limited protection from certain charges to someone who calls for help during an overdose, so the safest move in a suspected overdose is always to call 911. Another important harm reduction measure in Wisconsin is that fentanyl test strips are legal and distributed free at many pharmacies and harm-reduction sites. Here you can learn the basics of recognizing and responding to an overdose.
If a return to opioid use happens, it is a common and manageable part of treating a chronic condition, not a failure. So, carrying naloxone is simply part of staying safe.
Common Questions About MOUD in Wisconsin
Does BadgerCare Plus pay for opioid use disorder treatment?
Yes. Wisconsin Medicaid (BadgerCare Plus, through ForwardHealth) covers all three medications: methadone, buprenorphine and naltrexone (Wisconsin DHS). Preferred buprenorphine-naloxone products generally do not need prior authorization, but some other products do; be sure to confirm current details with the provider when you call.
Can I start treatment without coming in first?
Often, yes. As of June 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit, under federal rules in effect through 2026. Methadone for opioid use disorder is still started and dispensed through an opioid treatment program, though some programs can begin with a telehealth visit.
Do I have to go to a clinic every day for methadone?
Not indefinitely. Methadone for opioid use disorder is dispensed through an opioid treatment program, and federal rules updated in 2024 allow up to a 28-day take-home supply for patients who are stable in treatment. The program decides take-home eligibility based on your progress.
What is the difference between methadone and Suboxone?
Both reduce withdrawal and cravings and both are effective. Methadone is dispensed daily through an opioid treatment program, whereas Suboxone (buprenorphine-naloxone) can be prescribed in an office and filled at a pharmacy. The right choice depends on your history and needs and is best made with a clinician. Here is a fuller comparison, and you can also read whether you can become addicted to methadone.
What does treatment cost without insurance?
Many Wisconsin programs offer sliding-scale fees, and state and federal grant funding supports treatment for people who do not qualify for BadgerCare Plus. Costs vary by program and medication, so ask about self-pay rates and assistance when you call.
Last reviewed and disclosures
Last reviewed July 2026.
Sources:
- Wisconsin Department of Health Services, opioid settlement funds and 2023 to 2024 overdose decline (2026)
- Wisconsin DHS, naloxone access and statewide standing order
- Wisconsin Administrative Code Chapter DHS 75, office-based opioid treatment and State Opioid Treatment Authority
- KFF, opioid overdose death trends by state (2026)
- SAMHSA and DEA federal MOUD and telemedicine rules (2023 to 2026)
Methadone Centers is a treatment-discovery and education resource, not a medical provider, and does not provide medical advice, diagnosis, or treatment. Always consult a qualified clinician about your care.
Some calls to numbers on this site may be answered by a sponsored helpline. There is no obligation to enter treatment, and you can also contact providers in the listings directly.